

Netmeds First Membership
Quick Links
Introduction About EDI TABLET
EDI TABLET contains Itopride which belongs to a group of medicine called Gastroprokinetic agents. It is used in the management of gastrointestinal symptoms of functional dyspepsia (indigestion) and non-ulcer dyspepsia (bloating, upper abdominal pain, anorexia, heartburn, nausea and vomiting). EDI TABLET is not recommended for use in patients with an increase in gastrointestinal motility (gastrointestinal bleeding, mechanical obstruction or perforation).
The safety and effectiveness of EDI TABLET in pregnant women and children under 16 years of age has not yet been established. It is not recommended for use in breastfeeding women. EDI TABLET should be used with caution in elderly patients. The most common side effects of taking EDI TABLET are diarrhoea, constipation, headache, abdominal pain, dizziness or feeling irritated. Consult your doctor if symptoms do not improve.
Uses Of EDI TABLET
- Manage gastrointestinal symptoms of functional and non-ulcer indigestion (chronic gastritis)
How EDI TABLET Works
EDI TABLET stops the activity of dopamine D2 receptor and increases acetylcholine (messenger in the nervous system) concentrations which accelerates gastric emptying, improves gastric movement and reduces nausea and vomiting.
How to use EDI TABLET
Always take EDI TABLET exactly as prescribed by your doctor. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the right dose and duration for you depending on your age, body weight and disease condition.
Side Effects Of EDI TABLET
Common
- diarrhoea
- constipation
- headache, dizziness
- abdominal pain
- feeling irritated
How To Manage Side Effects
Constipation:
Take fiber-rich foods such as fresh fruit, vegetables and cereals, and drink plenty of water. Exercise more regularly. Consult your doctor if symptoms do not improve.
Headache:
Rest and drink plenty of fluids. Apply a cold, wet cloth, or ice pack to your forehead. Rest in a quiet, comfortable, dark room. Consult your doctor if symptoms do not improve.
Diarrhoea:
Drink a lot of fluids, such as water or squash, to avoid dehydration. Do not take any other medicines without speaking to a doctor. Consult your doctor if symptoms do not improve.
Stomach pain:
Try to rest and relax. You can eat and drink slowly or small have frequent meals. Keeping a heat pad on your stomach may also help. If pain persists, speak to your doctor.
Warning & Precautions

Pregnancy
EDI TABLET is not recommended for use in pregnant women unless the benefits outweigh the potential risks. Consult your doctor before taking it.

Breastfeeding
EDI TABLET is not recommended for use in breastfeeding women as it is excreted in the breast milk. Your doctor will decide whether to discontinue nursing or to discontinue the drug, considering the importance of the drug to the mother.

Allergy
Do not take EDI TABLET if you are allergic (hypersensitive) to this medicine or any other ingredients in this medicine.
Others
EDI TABLET is not recommended for use if you:
- have an increase in gastrointestinal motility (gastrointestinal bleeding, mechanical obstruction or perforation)
Use in pediatrics:
The safety and effectiveness of EDI TABLET in children under 16 years of age has not been established yet. Consult your doctor before using it.
Use in geriatrics:
EDI TABLET should be used with caution in elderly patients due to greater incidence of kidney, liver or other problems. Consult your doctor before using it.
Interactions
A. Drug-Drug Interaction:
Before taking EDI TABLET inform your doctor if you are taking any of the following medicines:
- anti-ulcer drugs (Ex. cimetidine, ranitidine, teprenone and cetraxate) to manage gastric ulcers
- anticholinergic drugs (Ex. dicyclomine) to manage irritable bowel syndrome
Overdosage:
If you or anyone else accidentally use too much of EDI TABLET, consult your doctor immediately or visit the nearby hospital.
Synopsis
Drug | : | Itopride |
Pharmacological Category | : | Gastroprokinetic agents |
Therapeutic Indication | : | Dyspepsia |
Dosage Forms | : | Tablet, Capsule |
More Information
- Store at room temperature 15-30°C
- Keep out of reach of children
FAQs About EDI TABLET
What is EDI TABLET used for?
EDI TABLET is used in the management of gastrointestinal symptoms of functional dyspepsia (indigestion), non-ulcer dyspepsia (bloating, upper abdominal pain, anorexia, heartburn, nausea and vomiting).
How does EDI TABLET work?
EDI TABLET stops the activity of dopamine D2 receptor and increases acetylcholine (messenger in the nervous system) concentrations which accelerates gastric emptying, improves gastric movement and reduces nausea and vomiting.
Does EDI TABLET cause diarrhoea?
Yes, EDI TABLET may cause diarrhoea as a common side effect. Drink a lot of fluids, such as water or squash, to avoid dehydration. Do not take any other medicines without speaking to a doctor. Consult your doctor if symptoms do not improve.
Can EDI TABLET be used in breastfeeding women?
EDI TABLET is not recommended for use in breastfeeding women as it is excreted in the breast milk. Your doctor will decide whether to discontinue nursing or to discontinue the drug, considering the importance of the drug to the mother.
Can EDI TABLET be used along with dicyclomine?
Do not take anticholinergic drugs (Ex. dicyclomine) along with this medicine as it can affect the way this medicine acts on your body. Consult your doctor before taking any other medicines.
References
1. KD. Tripathi. Essentials of medical pharmacology. Seventh edition. 2013. Chapter – 47, Antiemetic, Prokinetic and Digestant Drugs. 2013. Page – 663, 667.
2. Xuan Huang, Bin Lv, Shuo Zhang, Yi-Hong Fan, and Li-Na Meng. Itopride therapy for functional dyspepsia: A meta-analysis. National Library of Medicine, National Institute of Health. Pubmed Central. December 2012 [Accessed on 6th October 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3544044/
3. Eman Mohamed Elmokadem , Radwa Maher El Borolossy , Ahmed M Bassiouny , Maha Gamil Hanna , Ebtissam Abdel Ghaffar Darweesh , Nagwa A Sabri. The efficacy and safety of itopride in feeding intolerance of critically ill patients receiving enteral nutrition: a randomized, double-blind study. National Library of Medicine, National Institute of Health. Pubmed.gov. March 2021. [Accessed on 6th October 2022] https://pubmed.ncbi.nlm.nih.gov/33740892/
4. Abbott laboratories limited. Itopride Hydrochloride. [Revised on September 2007] [Accessed on 6th October 2022] https://www.medicine.abbott/content/dam/bss/divisionalsites/epd/pk/Product%20Information/Leaflet%20Ganaton%2050.pdf